Not checked for notices yet.
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
Garcia Michael E, Seiden Michael V, June Carl and 4 more
Journal of Translational Medicine · 2007
Cited by papers we hold 3
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment · 2017No notice
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer · 2015No notice
- Interleukin 12 a Key Immunoregulatory Cytokine in Infection Applications · 2010No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.